GlassScriptPhysician profile
Jesse A Taylor
NPI 1871785873
$26,968.40
in general payments reported to CMS, 2019-2025
10 companies · $1,582 in 2025
The $1,582 reported for 2025 was more than what 81% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,643 · 2020: $4,800 · 2021: $1,161 · 2022: $16K · 2023: $1,411 · 2024: $625 · 2025: $1,582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,958 · Travel and Lodging: $1,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,957.71 |
| Travel and Lodging | $1,660.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $15,168.98 | 2020-2025 | Trumatch |
| Synthes Gmbh | $7,550.00 | 2021-2022 | |
| Synthes USA Products LLC | $1,545.00 | 2019 | |
| Depuy Synthes Sales INC. | $1,468.60 | 2019-2025 | Trumatch, Na, Matrixcombo |
| Tela Bio, INC. | $446.25 | 2021-2022 | |
| Axogen | $241.18 | 2021-2024 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Kls-Martin L.P. | $172.59 | 2020-2021 | |
| Kerecis Limited | $144.64 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Rti Surgical, INC | $135.41 | 2025 | |
| Allergan, INC. | $95.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.